Idioma: Inglés
Publicado por Birkhauser, Switzerland, 2005
ISBN 10: 3764365951 ISBN 13: 9783764365950
Librería: The Book Exchange, Macclesfield, CHESH, Reino Unido
EUR 16,03
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Near Fine. No Jacket. 3764365951. Pictorial board hardcover, from closed pharmaceutical company library. Lending record shows this book has never been borrowed. 344 pages, index, refs, illustrated with charts, photos and diagrams. A comprehensive overview of disease-modifying antirheumatic drugs (DMARDs). The introductory general chapters deal with the chemistry of DMARDs, their use in therapy, pharmacoeconomics, and a survey of opinion leaders in the field; the following specific chapters characterize each agent with regard to mechanism of action, therapy, pharmacology, efficacy, toxicity, and monitoring. For each agent some background is given, recent developments and influence of the treatment on patients` quality of life and long-term outcomes are presented. Contents clean, tight and bright. Book.
Librería: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Alemania
EUR 12,00
Cantidad disponible: 2 disponibles
Añadir al carritoXII, 343 p. Hardcover Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Gestempelt. Progress in Inflammation Research. Sprache: Englisch.
Librería: Lexington Books Inc, Idaho Falls, ID, Estados Unidos de America
EUR 49,68
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Good. Good+; Contents are tight and clean; Ex-Library; Hard Cover; Birkhauser; 2005; 0.
Librería: Basi6 International, Irving, TX, Estados Unidos de America
EUR 98,73
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Librería: Romtrade Corp., STERLING HEIGHTS, MI, Estados Unidos de America
EUR 98,99
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
EUR 70,16
Cantidad disponible: 1 disponibles
Añadir al carritoHardcover. Condición: Like New. Like NewLIKE NEW. book.
Idioma: Holandés
Publicado por Bohn Stafleu van Loghum, 2017
ISBN 10: 9036813352 ISBN 13: 9789036813358
Librería: Mooney's bookstore, Den Helder, Holanda
EUR 48,79
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Very good.
Idioma: Inglés
Publicado por Taylor & Francis Group, 1997
ISBN 10: 0824795164 ISBN 13: 9780824795160
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 143,40
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Used. pp. 728 1st Edition.
Idioma: Inglés
Publicado por Taylor & Francis Group, 1997
ISBN 10: 0824795164 ISBN 13: 9780824795160
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 146,51
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Used. pp. 728.
Librería: Ria Christie Collections, Uxbridge, Reino Unido
EUR 174,75
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. In.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel, 2004
ISBN 10: 3764365951 ISBN 13: 9783764365950
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.
EUR 235,11
Cantidad disponible: 2 disponibles
Añadir al carritoHardcover. Condición: Brand New. 1st edition. 343 pages. German language. 9.25x6.50x1.00 inches. In Stock.
Idioma: Holandés
Publicado por Bohn Stafleu van Loghum, 2017
ISBN 10: 9036813352 ISBN 13: 9789036813358
Librería: Mooney's bookstore, Den Helder, Holanda
EUR 92,81
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Very good.
Idioma: Inglés
Publicado por Taylor & Francis Group, 1997
ISBN 10: 0824795164 ISBN 13: 9780824795160
Librería: Majestic Books, Hounslow, Reino Unido
EUR 157,15
Cantidad disponible: 1 disponibles
Añadir al carritoCondición: Used. pp. 728 This item is printed on demand.
Librería: preigu, Osnabrück, Alemania
EUR 141,20
Cantidad disponible: 5 disponibles
Añadir al carritoBuch. Condición: Neu. Antirheumatic Therapy: Actions and Outcomes | Richard O. Day (u. a.) | Buch | xiii | Englisch | 2004 | Springer Basel | EAN 9783764365950 | Verantwortliche Person für die EU: Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand.
Idioma: Inglés
Publicado por Birkhäuser Basel, Birkhäuser Basel Dez 2004, 2004
ISBN 10: 3764365951 ISBN 13: 9783764365950
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 160,49
Cantidad disponible: 1 disponibles
Añadir al carritoBuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Our goal for this book is to examine the contemporary therapy of rheumatoid arthritis (RA) from the increasingly important perspective of impact upon quality of life, costs and long-term health outcomes. For too long the focus has been on short term, symptomatic, and surrogate indicator outcomes. Yet RA is a life-long disor der with the majority of impact on an individual patient many years following onset. Further, even in the short-term, researchers and rheumatologists have tended to emphasize measurements of disease activity such as joint counts, ESR and physi cian's opinion as to the amount of disease activity present. It is only relatively recently that measures of structural damage, quality of life and impact on broad domains of health have been given increasing emphasis. Also, the significance of early treatment of RA in order to optimise long-term outcomes has a relatively short history [1]. We have been focussed on the disease processes as surrogates for long term outcomes. Until the short-term process measures are validated as surrogates of long-term effects we should also turn our attention to outcomes of disease and the impact of our management on those outcomes [2). Inour view, this book is especially timely. We are at the dawn of a revolution in the management of RA and other complex immunological inflammatory disorders because their molecular, genetic and environmental mechanisms are being unrav elled. Inthe process, we are revealing a substantial number of novel and significant targets for pharmacotherapy.Springer Basel AG in Springer Science + Business Media, Heidelberger Platz 3, 14197 Berlin 364 pp. Englisch.